JC 7/18/2022: presented By our two fellows Dr. Bellman and Dr. Rooney; discussing topic: Valoctocogene Roxaparvovec Gene Therapy for Hemophilia A(a 2.5 million dollar treatment) #MedTwitter#MedEd@leshune@KUHemOncFellow@Oncn
Today, @KUcancercenter became an officially designated @theNCI Comprehensive Cancer Center!
Honored to be part of an institution that is constantly growing and evolving in order to provide our patients with the best care #WeAreNCIComprehensive